Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
Butyl (3-(4-((1H-imidazol-1-yl)methyl)phenyl)-5-isobutylthiophen-2-yl)sulfonylcarbamate REF: IN-DA00DM1RCAS: 477775-14-7 | 98% | A consultar | Mar 03 Dic 24 | |
AT2 receptor agonist C21 REF: 3D-CUA77514CAS: 477775-14-7 | Min. 95% | A consultar | Mar 14 Ene 25 | |
Buloxibutid REF: TM-T14337CAS: 477775-14-7 | 97.68% - 98.58% | 49,00 €~1.465,00 € | Mar 21 Ene 25 |
Butyl (3-(4-((1H-imidazol-1-yl)methyl)phenyl)-5-isobutylthiophen-2-yl)sulfonylcarbamate
CAS:477775-14-7
Fórmula:
C23H29N3O4S2
Pureza:
98%
Forma y color:
Solid
Peso molecular:
475.6241
Ref: IN-DA00DM1R
1mg | 76,00 € | ||
5mg | 126,00 € | ||
10mg | 193,00 € | ||
25mg | 233,00 € | ||
50mg | 494,00 € | ||
100mg | 558,00 € | ||
250mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 3 de Diciembre de 2024
AT2 receptor agonist C21
CAS:477775-14-7
C21 is a potent and selective agonist of the AT2 receptor. It has been shown …
Fórmula:
C23H29N3O4S2
Pureza:
Min. 95%
Peso molecular:
475.6 g/mol
Ref: 3D-CUA77514
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 14 de Enero de 2025
Buloxibutid
CAS:477775-14-7
Buloxibutid: a novel AT2 receptor agonist, Ki=0.4 nM (AT2), 10 μM (AT1).
Fórmula:
C23H29N3O4S2
Pureza:
97.68% - 98.58%
Forma y color:
Solid
Peso molecular:
475.62
Ref: TM-T14337
1mg | 49,00 € | ||
5mg | 94,00 € | ||
10mg | 150,00 € | ||
25mg | 268,00 € | ||
50mg | 422,00 € | ||
100mg | 730,00 € | ||
500mg | 1.465,00 € | ||
1mL*10mM (DMSO) | 96,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025